Clinical Trial Update: Intravitreal Adalimumab in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intravitreal adalimumab for choroidal neovascularization secondary to age-related macular degeneration has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Choroidal Neovascularization

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Age-Related Macular Degeneration, Choroidal Neovascularization | Phase 2 | Status: COMPLETED